Dupilumab Reduces Urticaria Activity, Itch, and Hives in Patients with Chronic Spontaneous Urticaria Regardless of Baseline Serum Immunoglobulin E Levels

• 主要な著者: Marcus Maurer (著者), Thomas B. Casale (著者), Sarbjit S. Saini (著者), Moshe Ben-Shoshan (著者), Elizabeth Laws (著者), Jennifer Maloney (著者), Deborah Bauer (著者), Allen Radin (著者), Melanie Makhija (著者)
• フォーマット: 図書
• 出版事項: Adis, Springer Healthcare, 2024-07-01T00:00:00Z.
• 主題: article
• オンライン･アクセス: Connect to this object online.

Abstract Introduction In chronic spontaneous urticaria (CSU), interleukin (IL)-4 and IL-13 may promote mast cell activation directly via IL-4 receptor expression, or indirectly via upregulated immunoglobulin E (IgE) production. Dupilumab significantly improved CSU signs and symptoms in the phase 3,...